Tectonic Therapeutic (TECX) Non Operating Income (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Non Operating Income came in at $2.1 million in Q1 2026, down 13.88% year-on-year from $2.4 million in Q1 2025, and down 19.03% on a QoQ basis from $2.5 million in Q4 2025.
Tectonic Therapeutic (TECX) Non Operating Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Non Operating Income data on file, last reported at $2.1 million in Q1 2026.
- On a quarterly basis, Non Operating Income fell 13.88% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $10.8 million, a 130.41% increase from a year earlier, with the FY2025 full-year figure at $11.1 million, up 33581.82% from the prior year.
- Non Operating Income for Q1 2026 stood at $2.1 million, down from $2.5 million in the prior quarter.
- Over the last five years, Non Operating Income for TECX reached as high as $3.3 million in Q2 2025 and fell as low as -$2.3 million in Q1 2024.
- Historically, Non Operating Income has averaged $868117.6 across 5 years, with a median of $263000.0 in 2023.
- Across the five-year window, Non Operating Income tumbled 2666.67% in 2022 and surged 3100.0% in 2024, its largest moves.
- Year by year, Non Operating Income stood at $223000.0 in 2022, then jumped by 574.89% to $1.5 million in 2023, then gained by 7.51% to $1.6 million in 2024, then surged by 57.23% to $2.5 million in 2025, then decreased by 19.03% to $2.1 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $2.1 million in Q1 2026, $2.5 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Tectonic Therapeutic | 571.52 Mn | 571.52 Mn | - | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 2.54 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -2.25 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 176,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 223,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | -280,000.00 |
| Mar 31, 2022 | -415,000.00 |
| Dec 31, 2021 | -265,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | -12,000.00 |